Epidermolysis bullosa aquisita following immune‐checkpoint inhibitor treatment for metastatic melanoma

A case of epidermolysis bullosa aquisita following immunotherapy for melanoma. This adds to the repertoire of subepidermal blistering disorders documented following immune checkpoint therapy.

Bibliographische Detailangaben

Veröffentlicht in:	Clinical and experimental dermatology 2022-06, Vol.47 (6), p.1198-1199
Hauptverfasser:	O'Connor, Jane, Zhang, Shuai, Galante, Joao R., Mee, John, Semkova, Kristina, Parkar, Rosemeen, Groves, Richard
Format:	Artikel
Sprache:	eng
Schlagworte:	Epidermolysis bullosa Epidermolysis Bullosa - pathology Epidermolysis Bullosa Acquisita Humans Immune checkpoint Immune Checkpoint Inhibitors - adverse effects Immunologic Factors - therapeutic use Immunotherapy Melanoma Melanoma - drug therapy Metastases Neoplasms, Second Primary Skin Diseases, Vesiculobullous
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!